Company
COO
2024-12-16–present
Jebediah T. Ledell
COO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jebediah T. Ledell
The company reported in an 8-K filed May 12, 2025 that Jebediah T. Ledell resigned as Chief Operating Officer, effective May 12, 2025. The company reported in an 8-K filed December 16, 2024 that Jebediah T. Ledell was appointed Chief Operating Officer, effective December 16, 2024.
“On May 12, 2025, Jebediah T. Ledell notified KalVista Pharmaceuticals, Inc. (the "Company") of his decision to resign from his position as Chief Operating Officer of the Company, effective immediately.”
“Effective December 16, 2024, the Board of Directors (the "Board") of KalVista Pharmaceuticals, Inc. (the "Company") appointed Jebediah T. Ledell as the Company's Chief Operating Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
COO
SEC 8-K
Current2024-12-16–present
-
Organization not stated
COO
SEC 8-K
2024-12-16–2025-05-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: Chief Operating Officer
-
Executive change Appointed: Chief Operating Officer